Invention Grant
US08968749B2 Vaccine composition and immunization method 有权
疫苗组成和免疫方法

Vaccine composition and immunization method
Abstract:
The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Leishmania.
Public/Granted literature
Information query
Patent Agency Ranking
0/0